A Mathematical Model of the Pathogenesis, Prevention, and Reversal of Type 2 Diabetes.

Type 2 diabetes (T2D) is generally thought to result from the combination of 2 metabolic defects, insulin resistance, which increases the level of insulin required to maintain glucose within the normal range, and failure of insulin-secreting pancreatic β-cells to compensate for the increased demand. We build on a mathematical model pioneered by Topp and colleagues to elucidate how compensation succeeds or fails. Their model added a layer of slow negative feedback to the classic insulin-glucose loop in the form of a slow, glucose-dependent birth and death law governing β-cell mass. We add to that model regulation of 2 aspects of β-cell function on intermediate time scales. The model quantifies the relative contributions of insulin action and insulin secretion defects to T2D and explains why prevention is easier than cure. The latter is a consequence of a threshold separating the normoglycemic and diabetic states (bistability), which also underlies the success of bariatric surgery and acute caloric restriction in rapidly reversing T2D. The threshold concept gives new insight into "Starling's Law of the Pancreas," whereby insulin secretion is higher for prediabetics and early diabetics than for normal individuals.

[1]  R. Rizza,et al.  β-Cell Mass and Turnover in Humans , 2012, Diabetes Care.

[2]  S. Bonner-Weir,et al.  Five Stages of Evolving-Cell Dysfunction During Progression to Diabetes , 2004 .

[3]  S. Bonner-Weir,et al.  Five stages of evolving beta-cell dysfunction during progression to diabetes. , 2004, Diabetes.

[4]  R. Rizza,et al.  β-Cell Replication Is the Primary Mechanism Subserving the Postnatal Expansion of β-Cell Mass in Humans , 2008, Diabetes.

[5]  Leslie S Satin,et al.  Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes. , 2015, Molecular aspects of medicine.

[6]  S. Piccoli,et al.  Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes. , 2011, The Journal of clinical endocrinology and metabolism.

[7]  K. Brayman,et al.  Evidence that low-grade systemic inflammation can induce islet dysfunction as measured by impaired calcium handling. , 2010, Cell calcium.

[8]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[9]  P. Carlsson,et al.  A Low-Oxygenated Subpopulation of Pancreatic Islets Constitutes a Functional Reserve of Endocrine Cells , 2011, Diabetes.

[10]  S. Bonner-Weir,et al.  Critical reduction in beta-cell mass results in two distinct outcomes over time. Adaptation with impaired glucose tolerance or decompensated diabetes. , 2003, The Journal of biological chemistry.

[11]  S. Haneuse,et al.  A Multisite Study of Long-term Remission and Relapse of Type 2 Diabetes Mellitus Following Gastric Bypass , 2012, Obesity Surgery.

[12]  Benjamin S. Aribisala,et al.  Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol , 2011, Diabetologia.

[13]  The hyperbolic law—a 25-year perspective , 2005, Diabetologia.

[14]  Robert A. Rizza,et al.  β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.

[15]  A. Sherman,et al.  Chronic Glucose Exposure Systematically Shifts the Oscillatory Threshold of Mouse Islets: Experimental Evidence for an Early Intrinsic Mechanism of Compensation for Hyperglycemia. , 2016, Endocrinology.

[16]  M. Igoillo-Esteve,et al.  The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation , 2010, Diabetologia.

[17]  Katherine C. Chen,et al.  Sniffers, buzzers, toggles and blinkers: dynamics of regulatory and signaling pathways in the cell. , 2003, Current opinion in cell biology.

[18]  Melissa M. Parker,et al.  Incidence of Remission in Adults With Type 2 Diabetes: The Diabetes & Aging Study , 2014, Diabetes Care.

[19]  J. Henquin,et al.  Triggering and amplifying pathways of regulation of insulin secretion by glucose. , 2000, Diabetes.

[20]  R. Miura,et al.  A Model of β -Cell Mass, Insulin, and Glucose Kinetics: Pathways to Diabetes , 2000 .

[21]  R. Dankner,et al.  Insulin Resistance and Hyperinsulinemia , 2008, Diabetes Care.

[22]  D. Drucker,et al.  Biology of incretins: GLP-1 and GIP. , 2007, Gastroenterology.

[23]  B. Hansen,et al.  Hepatic glucose production and insulin sensitivity preceding diabetes in monkeys. , 1989, The American journal of physiology.

[24]  A. De Gaetano,et al.  Mathematical models of diabetes progression. , 2008, American journal of physiology. Endocrinology and metabolism.

[25]  J. McGarry,et al.  What if Minkowski had been ageusic? An alternative angle on diabetes. , 1992, Science.

[26]  R. Hanson,et al.  Progression to Type 2 Diabetes Characterized by Moderate Then Rapid Glucose Increases , 2007, Diabetes.

[27]  B. Glaser,et al.  Large islets, beta-cell proliferation, and a glucokinase mutation. , 2010, The New England journal of medicine.

[28]  G. Dohm,et al.  Diabetes: Have We Got It All Wrong? , 2012, Diabetes Care.

[29]  J. Holst,et al.  Early Enhancements of Hepatic and Later of Peripheral Insulin Sensitivity Combined With Increased Postprandial Insulin Secretion Contribute to Improved Glycemic Control After Roux-en-Y Gastric Bypass , 2014, Diabetes.

[30]  Bard Ermentrout,et al.  Simulating, analyzing, and animating dynamical systems - a guide to XPPAUT for researchers and students , 2002, Software, environments, tools.

[31]  C. Nichols,et al.  Chronic Antidiabetic Sulfonylureas In Vivo: Reversible Effects on Mouse Pancreatic β-Cells , 2008, PLoS medicine.

[32]  M. Bessler,et al.  Very Low–Calorie Diet Mimics the Early Beneficial Effect of Roux-en-Y Gastric Bypass on Insulin Sensitivity and β-Cell Function in Type 2 Diabetic Patients , 2013, Diabetes.

[33]  B. Topp,et al.  Dynamics of insulin sensitivity, -cell function, and -cell mass during the development of diabetes in fa/fa rats. , 2007, American journal of physiology. Endocrinology and metabolism.

[34]  J. Leahy,et al.  Mechanism of compensatory hyperinsulinemia in normoglycemic insulin-resistant spontaneously hypertensive rats. Augmented enzymatic activity of glucokinase in beta-cells. , 1994, The Journal of clinical investigation.

[35]  H. A. van den Berg,et al.  Interaction of fast and slow dynamics in endocrine control systems with an application to β-cell dynamics. , 2012, Mathematical biosciences.

[36]  C. Nichols,et al.  Pancreatic β cell dedifferentiation in diabetes and redifferentiation following insulin therapy. , 2014, Cell metabolism.

[37]  S. Bonner-Weir,et al.  Sleeping Islets and the Relationship Between β-Cell Mass and Function , 2011, Diabetes.

[38]  E. Fliers,et al.  Hepatic and peripheral insulin sensitivity do not improve 2 weeks after bariatric surgery , 2013, Obesity.

[39]  F. Ashcroft,et al.  Control of pancreatic β cell regeneration by glucose metabolism. , 2011, Cell metabolism.

[40]  R. DeFronzo The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.

[41]  B. Hansen,et al.  Beta-cell hyperresponsiveness: earliest event in development of diabetes in monkeys. , 1990, The American journal of physiology.

[42]  P. Goel Insulin resistance or hypersecretion? The βIG picture revisited. , 2015, Journal of theoretical biology.

[43]  Haiying Chen,et al.  Association of an intensive lifestyle intervention with remission of type 2 diabetes. , 2012, JAMA.

[44]  C. Talchai,et al.  Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure , 2012, Cell.

[45]  P. Rorsman,et al.  Exocytotic Properties of Human Pancreatic β‐cells , 2009, Annals of the New York Academy of Sciences.

[46]  M. Jensen,et al.  Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. , 2009, The American journal of medicine.

[47]  C. Sempoux,et al.  Pancreatic β‐cell mass in European subjects with type 2 diabetes , 2008, Diabetes, obesity & metabolism.

[48]  M. Fantone,et al.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1997, Diabetes Care.

[49]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.